Journal
RESPIRATORY MEDICINE
Volume 99, Issue 3, Pages 298-307Publisher
W B SAUNDERS CO LTD
DOI: 10.1016/j.rmed.2004.08.009
Keywords
non-small-cell lung cancer (NSCLC); epidermal growth factor receptor (EGFR); EGFR tyrosine kinase inhibitor; gefitinib; 'Iressa'